In fiscal 2026, which ended Jul 31, 2026, Naploy Corp. used $13,651 of cash from operations, up 35.5% from the year before.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jul 31, 2026
|
FY 2025
Jul 31, 2025
|
FY 2024
Jul 31, 2024
|
|---|---|---|---|
| Operating | |||
| Depreciation and amortization |
—
|
—
|
0
|
| Operating cash flow |
-0
+35.5%
|
-0
-24.5%
|
-0
|
| Investing | |||
| Investing cash flow |
—
|
0
+100.0%
|
-0
|
| Financing | |||
| Financing cash flow |
0
+1276.8%
|
0
-97.8%
|
0
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- NPLY (OTC)
- Fiscal year ends
- July 31
- Incorporated in
- WY
- Headquarters
- District Abuja, Fct, Nigeria
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1978111
Other Services-Health Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.